Oakwood Labs is a world leading CDMO with 25+ years of experience developing and manufacturing long acting injectables (LAI). Our patented Chroniject™ technology provides the ability to control particle size, customize release durations from weeks to years, and minimize residual solvents to achieve critical quality attributes. We are a one-stop shop CDMO for initial feasibility through to FDA-approved commercial supply, for various drug modalities and therapy areas with lot-to-lot reproducibility, reliable scalability, and quick timelines.
Oakwood also has a fully approved GMP aseptic facility and serves as a CMO with open capacity. We have the capability to manufacture aqueous, solvent-based, and suspension filled vials, as well as high-potency and lyophilized products.